No Products in the Cart
The U.S. Food and Drug Administration (FDA) recognized cannabidiol as a medicine for the first time on June 25, 2018 for the treatment of two severe pediatric seizure disorders, Lennox-Gastaut syndrome and Dravet syndrome. It later was approved by the agency to help treat seizures associated with tuberous sclerosis complex.
CBD shows strong promises in helping those struggling with Opioid addiction by Cannabinoids ability to reverse the brain's environment. Neuroscientist suggests CBD as a treatment option.